MyMD Pharmaceuticals Inc.

04/05/2022 | Press release | Archived content

MyMD Pharmaceuticals® Accelerates Pace of New Patient Dosing in Phase 2 Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan